Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Vivos Therapeutics (VVOS) Times Interest Earned (2020 - 2022)

Vivos Therapeutics' Times Interest Earned history spans 3 years, with the latest figure at -$150.19 for Q3 2022.

  • Quarterly results put Times Interest Earned at -$150.19 for Q3 2022, up 75.44% from a year ago — trailing twelve months through Jun 2023 was -$583.11 (down 393.59% YoY), and the annual figure for FY2021 was -$304.36, down 142.68%.
  • Times Interest Earned for Q3 2022 was -$150.19 at Vivos Therapeutics, up from -$188.22 in the prior quarter.
  • In the past five years, Times Interest Earned ranged from a high of $2177.5 in Q4 2021 to a low of -$4061.0 in Q2 2021.
  • The 3-year median for Times Interest Earned is -$174.71 (2022), against an average of -$638.26.
  • Peak annual rise in Times Interest Earned hit 700.09% in 2021, while the deepest fall reached 5722.38% in 2021.
  • Year by year, Times Interest Earned stood at -$362.86 in 2020, then surged by 700.09% to $2177.5 in 2021, then plummeted by 106.9% to -$150.19 in 2022.
  • According to Business Quant data, Times Interest Earned over the past three periods came in at -$150.19, -$188.22, and -$174.71 for Q3 2022, Q2 2022, and Q1 2022 respectively.